Regeneron Pharmaceuticals, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.99
Forward P/E Ratio
11.41
PEG Ratio
-1.93
12.62
Price-to-Sales (TTM)
4.31
1.99
308.33
Market Cap
65.92B
55.29B
Is it profitable?
Net Profit Margin (TTM)
29.65%
Gross Profit Margin
81.43%
Diluted EPS (TTM)
40.94
14.55%
14.92B
Is it growing?
19.00%
-10.10%
Is it risky?
0.30
8.61
3.57
2.71B
Who owns it?
92.15%
2.03%
2.80%
105.02M
97.67M
Does it pay?
0.60%
8.74%
--
--
How much cash?
8.75B
5.01B
3.27B
86.04
- Price
- 635.45
- Percent Change
- +6.72 (1.07%)
- Previous Close
- 628.73
- Open
- 633.00
- Low
- 632.02
- High
- 640.77
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$635.45
From 52W Low
+33.36%
From 52W High
-22.61%
Today
+1.07%
1Y Change
+31.54%
6M
$718.36
3M
$764.93
1M
$702.27
Today
$635.45
From 52W Low
+33.36%
From 52W High
-22.61%
Today
+1.07%
1Y Change
+31.54%
6M
$718.36
3M
$764.93
1M
$702.27
Today
$635.45
Fairly Priced
within its 1-year price range
$635.45
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-9.5%
3M
-16.9%
6M
-11.5%
1Y
+31.5%
Rate of Change (ROC)
Accelerating
Price is falling 5.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Regeneron Pharmaceuticals, Inc.
- Founded
- 1988
- CEO
- Leonard S. Schleifer
- Employees
- 15,343
- Fiscal Year End
- Dec 31, 2024
- Address
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.regeneron.com
Indicators
Operating Cash Flow
5.01B
Net Income
4.42B
Backed by Cash
1.13
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
NASDAQ 100Index NASDAQ-100 - NDX |
S&P 500Index S&P 500 - SPX |
Indicators
Operating Cash Flow
5.01B
Net Income
4.42B
Backed by Cash
1.13
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.99
Forward P/E Ratio
11.41
PEG Ratio
-1.93
12.62
Price-to-Sales (TTM)
4.31
1.99
308.33
Market Cap
65.92B
55.29B
Is it profitable?
Net Profit Margin (TTM)
29.65%
Gross Profit Margin
81.43%
Diluted EPS (TTM)
40.94
14.55%
14.92B
Is it growing?
19.00%
-10.10%
Is it risky?
0.30
8.61
3.57
2.71B
Who owns it?
92.15%
2.03%
2.80%
105.02M
97.67M
Does it pay?
0.60%
8.74%
--
--
How much cash?
8.75B
5.01B
3.27B
86.04
- Price
- 635.45
- Percent Change
- +6.72 (1.07%)
- Previous Close
- 628.73
- Open
- 633.00
- Low
- 632.02
- High
- 640.77
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$635.45
From 52W Low
+33.36%
From 52W High
-22.61%
Today
+1.07%
1Y Change
+31.54%
6M
$718.36
3M
$764.93
1M
$702.27
Today
$635.45
From 52W Low
+33.36%
From 52W High
-22.61%
Today
+1.07%
1Y Change
+31.54%
6M
$718.36
3M
$764.93
1M
$702.27
Today
$635.45
Fairly Priced
within its 1-year price range
$635.45
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-9.5%
3M
-16.9%
6M
-11.5%
1Y
+31.5%
Rate of Change (ROC)
Accelerating
Price is falling 5.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Regeneron Pharmaceuticals, Inc.
- Founded
- 1988
- CEO
- Leonard S. Schleifer
- Employees
- 15,343
- Fiscal Year End
- Dec 31, 2024
- Address
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.regeneron.com
Related Heatmaps
NASDAQ 100Index NASDAQ-100 - NDX |
S&P 500Index S&P 500 - SPX |